Predictive ability of direct-to-consumer pharmacogenetic testing: when is lack of evidence really lack of evidence?

RRJ Kalf, Rachel Bakker, Cecile Janssens

Epidemiology

Research output: Contribution to journal › Article › Academic › peer-review

7 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	341-344
Number of pages	4
Journal	Pharmacogenomics
Volume	14
Issue number	4
DOIs	https://doi.org/10.2217/pgs.13.8
Publication status	Published - 2013

Research programs

EMC NIHES-01-64-03

Access to Document

10.2217/pgs.13.8

http://hdl.handle.net/1765/40825

Cite this

@article{b8a01f39284f4cf98f768e501287110f,

title = "Predictive ability of direct-to-consumer pharmacogenetic testing: when is lack of evidence really lack of evidence?",

author = "RRJ Kalf and Rachel Bakker and Cecile Janssens",

year = "2013",

doi = "10.2217/pgs.13.8",

language = "Undefined/Unknown",

volume = "14",

pages = "341--344",

journal = "Pharmacogenomics",

issn = "1462-2416",

publisher = "Taylor & Francis Ltd",

number = "4",

}

TY - JOUR

T1 - Predictive ability of direct-to-consumer pharmacogenetic testing: when is lack of evidence really lack of evidence?

AU - Kalf, RRJ

AU - Bakker, Rachel

AU - Janssens, Cecile

PY - 2013

Y1 - 2013

U2 - 10.2217/pgs.13.8

DO - 10.2217/pgs.13.8

M3 - Article

C2 - 23438877

SN - 1462-2416

VL - 14

SP - 341

EP - 344

JO - Pharmacogenomics

JF - Pharmacogenomics

IS - 4

ER -